Press release
MicroRNA Market Booming with RNA Therapy Research Surge, Growing at 13.2% CAGR (2025-2033) | Top Companies 2025 - Thermo Fisher Scientific Inc., QIAGEN N.V.
MicroRNA Market
The MicroRNA Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/microrna-market?sp
MicroRNA Market Landscape Analysis :
MicroRNA refers to small, non-coding RNA molecules that regulate gene expression post-transcriptionally, playing critical roles in cellular processes and disease pathways. The market for microRNA-based applications is growing rapidly, driven by demand for advanced diagnostic biomarkers, novel therapeutic targets, and personalized medicine tools across oncology, cardiovascular, and neurological fields.
MicroRNA Market Dynamics:
The global microRNA (miRNA) market is expanding due to rising chronic diseases like cancer, cardiovascular conditions, and diabetes. miRNAs serve as critical biomarkers for early diagnosis and personalized therapies due to their gene regulation roles. Aging populations and lifestyle-related health issues further drive demand for miRNA-based diagnostics. In oncology, miRNAs act as tumor suppressors or oncogenes, supporting precision medicine strategies. Increasing R&D investments and government-backed initiatives are fueling market growth.
MicroRNA Market: Recent Industry Developments
✅In July 2025 Presented late-breaking Phase 2b PARADIGM trial data for PrimeC in ALS, showing modulation of over 100 miRNAs (notably downregulating miR 199a 5p), improved iron regulation, slowed disease progression by 32.8%, and a 58% boost in survival-supporting progression to Phase 3
✅In April 2025 Novartis announced an agreement to acquire Regulus Therapeutics (NASDAQ: RGLS) for $0.8 billion upfront (with up to $0.9 billion in milestones). The deal brings farabursen, an anti miR 17 candidate for autosomal dominant polycystic kidney disease (ADPKD) that recently completed Phase 1b, into Novartis's pipeline
Strategic Players Driving the MicroRNA Market Forward:
Thermo Fisher Scientific Inc., QIAGEN N.V., Merck KGaA, Agilent Technologies Inc., Illumina Inc., NanoString Technologies Inc., Takara Bio Inc., New England Biolabs, GeneCopoeia Inc., and Promega Corporation, among others.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/microrna-market?sp
Research Methodology:
The global MicroRNA Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.
Segment Covered in the MicroRNA Market:
✒By Product Type: Instruments, Consumables
✒By Technology: Real-Time Polymerase Chain Reaction, Microarray, Next Generation Sequencing (NGS), Immunoassay, Other
✒By Application: Cancer, Infectious Diseases, Immunological Disorders, Cardiovascular Diseases, Neurological Diseases, Others
✒By End User: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Diagnostic Centers, Others
Regional Analysis for MicroRNA Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=microrna-market?sp
Most Frequently Asked Questions in the MicroRNA Market Research Industry:
➠ Who leads the MicroRNA industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do MicroRNA market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting MicroRNA market growth?
➠ What are the dominant sales and distribution strategies in the MicroRNA industry?
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription?sp
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MicroRNA Market Booming with RNA Therapy Research Surge, Growing at 13.2% CAGR (2025-2033) | Top Companies 2025 - Thermo Fisher Scientific Inc., QIAGEN N.V. here
News-ID: 4106356 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Biologics Contract Manufacturing Market Accelerates with Growing B …
Outsourced biologics manufacturing including monoclonal antibodies (mAbs), vaccines, and advanced therapies such as cell and gene treatments has become essential to driving biopharma innovation. According to DataM Intelligence, the global biologics contract manufacturing market was valued at USD 26.03 billion in 2024 and is projected to reach USD 83.47 billion by 2033, expanding at a CAGR of 14.0% between 2025 and 2033.
Download exclusive insights with our detailed sample report (Corporate…
United States Healthcare Data Monetization Market Fueled by Growing Demand for R …
Healthcare data monetization involves transforming patient, claims, EHR, genomic and device-generated information into actionable insights and services. Based on DataM Intelligence analysis, the market was valued at approximately USD 0.6 billion in 2024 and is projected to reach USD 1.35 billion by 2031, reflecting a compound annual growth rate (CAGR) of 19.2%.
The accelerating adoption of artificial intelligence, real-world evidence generation, and cloud analytics platforms are key drivers behind this rapid…
Plant-Based Meat Market 2025 | Growth Drivers, Key Players & Investment Opportun …
Market Size and Growth
Global Plant-based Meat Market reached USD 5.6 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 21.7 billion by 2031. The market is expected to exhibit a CAGR of 20.2% during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ In July 2025, Impossible Foods launched grilled plant-based chicken strips nationwide, expanding its product line to cater to the growing demand…
United States Detox Drinks Market Outlook | Market Drivers, Innovation & Investo …
Market Size and Growth
Global Detox Drinks Market is expected to exhibit a CAGR of 6.52% during the forecast period (2024-2031).
Key Development:
United States:
✅ In August 2025, PepsiCo launched its Prebiotic Cola, a soda with 30 calories, no artificial sweeteners, and three grams of prebiotic fiber. This move reflects the company's response to the growing demand for functional beverages.
✅ In May 2025, PepsiCo acquired prebiotic soda company Poppi for $1.95 billion,…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
